EP3448846
Nýmyndun indasóls
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
25.4.2017EP published:
26.5.2021EP application number:
17718558.4
EP translation filed:
26.7.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
24.4.2037Expiry date:
24.4.2025
Title:
SYNTHESIS OF INDAZOLES
Timeline
Today
25.4.2017EP application
26.5.2021EP Publication
26.7.2021Translation submitted
15.9.2021Registration published
24.4.2025Expires
Owner
Name:
Bayer Pharma AktiengesellschaftAddress:
Müllerstrasse 178, 13353 Berlin, DE
Inventor
Name:
THALER, TobiasAddress:
50935 Köln, DE
Name:
PLATZEK, JohannesAddress:
12621 Berlin, DE
Name:
GUIMOND, NicolasAddress:
42115 Wuppertal, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16167652Date:
29.4.2016Country:
EP
Classification
Categories:
C07D 401/12, A61K 31/4439, A61P 35/00, A61P 37/00, A61P 9/00, A61P 27/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 23.3.2022
Expires: 24.4.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 25.3.2023
Expires: 24.4.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 26.3.2024
Expires: 24.4.2025
Payer: Árnason Faktor ehf.